Companies/Avantor, Inc.

Company profile

Avantor, Inc.

NYSE: AVTR · Healthcare · Medical - Instruments & Supplies

PublicHQ Radnor, PACIK 0001722482Reports USD

#48 of 1,394 Healthcare companies by revenue36th-percentile growth

EA Score

68B

FH 71DQ 69GM 53SS 74

v0.1 · 65/100 weight · provisional

↑ filing timeliness, workforce scale · ↓ listing tenure, 3-yr revenue growth

Methodology →

Revenue TTM

$6.6B

Rev growth YoY (TTM)

-2.0%

Net income (FY)

-$530.2M

Employees

13,500

Market cap

$7.0B

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$6.6B$6.6B2025

Net income-$530.2M-$530.2M2025

Operating income-$246.2M-$246.2M2025

Total assets$11.8B$11.8B2025

Liabilities$6.2B$6.2B2025

Equity$5.6B$5.6B2025

Revenue trend

FY2020 – FY2025 · USD

$1.5B

FY20

$1.6B

FY20

$6.4B

FY20

$7.4B

FY20

$7.5B

FY22

$7.0B

FY23

$6.8B

FY24

$6.6B

FY25

Revenue by segment

Filed disclosures · FY2025

By product

Proprietary Materials And Consumables53%

Third Party Materials And Consumables47%

By geography

UNITED STATES50%

All Other Countries50%

The read

Avantor, Inc. booked $6.6B in FY2025 revenue, contracting 3.4% year over year — slower than 64% of Healthcare companies we track, at a -8.1% net margin.

Peers · Healthcare

Liquidia Corporation58C Lantheus Holdings, Inc.78B+PTC Therapeutics, Inc.72B Praxis Precision Medicines, Inc.61C

Key facts

CEOEmmanuel Ligner

SectorHealthcare

IndustryMedical - Instruments & Supplies

HeadquartersRadnor, PA

ExchangeNYSE: AVTR

Employees13,500

IPO date2019-05-17

Latest filings

8-K2026-05-12 10-Q2026-04-29 8-K2026-04-29 8-K2026-04-23 8-K2026-04-01 DEF 14A2026-03-27 8-K2026-02-11 10-K2026-02-11

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.